Biotech stocks collapse as investors abandon GMO corporations amid global economic turmoil
Biotech stocks have finally entered bear market territory, with stocks now down about 22% from their previous high.[1] History is repeating itself, as it so often does. Recall that in 1992 biotech stocks doubled — sometimes tripled — in value in just a matter of months. For a time, these stocks were the sweetheart of Wall Read More
